Dextromethorphan Inhibits Osteoblast Differentiation and Bone Regeneration of Rats With Subcritical‐Sized Calvarial Defects
Environmental Toxicology · 2025
DOI: 10.1002/tox.24447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2025. Verfasst von Yu-Cheng Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Bone Regeneration, Osteoblasts, Dextromethorphan, Skull. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Science and Technology Council, R.O.C, Kaohsiung Veterans General Hospital, National Science and Technology Council.
Abstract (Originalsprache)
The glutamatergic signaling pathway, which is mediated by N‐methyl‐D‐aspartate (NMDA) receptors, is crucial for osteoblast differentiation and bone function. Dextromethorphan (DXM), a widely used antitussive, is a noncompetitive antagonist of the NMDA receptor. However, the effects of DXM on osteoblast and bone regeneration remain unclear. The present study investigated the effects of DXM on osteogenesis in vitro and in vivo. A MC3T3‐E1 preosteoblast cell line was treated with varying concentrations of DXM. Real‐time‐quantitative polymerase chain reaction (RT‐qPCR) and Western‐blot analysis were performed to evaluate the expression of osteogenesis‐related runt‐related transcription factor 2 (RUNX2), osterix (OSX), osteocalcin (OCN), collagen type 1α (Col‐1α), and alkaline phosphatase (ALP) after DXM treatment. Zebrafish embryos were incubated with DXM, which had potential to affect the ossification of the vertebrae and skull, and analyzed using calcein staining. Furthermore, we used a rat calvarial defect model to assess the effects of DXM on bone regeneration by using microcomputed tomography. The results indicate that DXM inhibited extracellular mineralization, ALP activity, and the expression of osteogenic markers, namely RUNX2, OSX, OCN, Col‐1α, and ALP, in MC3T3‐E1 cells. DXM suppressed skeleton ossification in zebrafish and affected bone regeneration in rats with calvarial defects. However, the mineral density of the regenerated bones did not differ significantly between the DXM and control groups. The present study demonstrated that DXM negatively affects the osteogenic function of osteoblasts, leading to impaired skeletal development and bone regeneration. Thus, clinicians should consider the negative effects of DXM on bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan.
- Department of Orthopedics, Asia University Hospital, Taichung, Taiwan.
- Department of Orthopedics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Eternal Dental Clinic, Taichung, Taiwan.
- Department of Orthopedic Surgery, Pingtung Christian Hospital, Pingtung, Taiwan.
ORCID-Profile: Yu-Cheng Lai
Förderung
- National Science and Technology Council, R.O.C
- Kaohsiung Veterans General Hospital
- National Science and Technology Council
Zitieren
APA
Lai, Y. C., Yao, Z. K., Chang, T. C., Feng, C. W., Kuo, T. J., Luo, Y. W., Jean, Y. H., Lin, H. Y., & Wen, Z. H. (2025). Dextromethorphan Inhibits Osteoblast Differentiation and Bone Regeneration of Rats With Subcritical‐Sized Calvarial Defects. Environmental Toxicology. https://doi.org/10.1002/tox.24447
Vancouver
Lai YC, Yao ZK, Chang TC, Feng CW, Kuo TJ, Luo YW, et al. Dextromethorphan Inhibits Osteoblast Differentiation and Bone Regeneration of Rats With Subcritical‐Sized Calvarial Defects. Environmental Toxicology. 2025. doi:10.1002/tox.24447
BibTeX
@article{Lai2025,
author = {Lai, Yu-Cheng and Yao, Zhi-Kang and Chang, Tien-Chieh and Feng, Chien-Wei and Kuo, Tsu-Jen and Luo, Yi-Wei and Jean, Yen-Hsuan and Lin, Hugo Y-H and Wen, Zhi-Hong},
title = {Dextromethorphan Inhibits Osteoblast Differentiation and Bone Regeneration of Rats With Subcritical‐Sized Calvarial Defects},
journal = {Environmental Toxicology},
year = {2025},
doi = {10.1002/tox.24447}
}
EUVIMED